Pharmafile Logo

Fresenius Kabi Ltd.

Fresenius Kabi is the leading European provider of clinical nutrition and infusion therapy offering a unique and comprehensive range of products and services for both hospital and home settings. From our expertise in nutrition and infusion therapies, and through dedication to people through innovation we are committed to becoming the preferred partner worldwide for saving, treatment and caring for chronically ill patients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cestrian Court, Eastgate Way, Runcorn, Cheshire, WA7 1NT
+44 (0) 1928-533 533

 Latest Content from PMHub 

Bluedog expands into the US with the appointment of George Pearson as Client Solutions Director

Bluedog, a Lucid Group Company, has elevated and expanded its creative team into the US with the appointment of George Pearson as Client Solutions Director.George is a highly experienced medical...

What can soaps do for symptoms awareness?

The BBC’s EastEnders and Channel 5’s Neighbours are featuring ovarian cancer storylines. We recently saw the death of Sonya Rebecchi, one of the lead characters in Neighbours, from the disease....

Apex and Lumentium bring a new experience to the UK event market

Specialist pharma conference and event management company Apex has signed an exclusive deal to become the sole representative of Lumentium in the UK.

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director

Press Releases | April 29, 2019 | OPEN Health

OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Press Releases | April 26, 2019 | Resonant Group

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

04 A Healthy Ambience

Creating a Lifeline to the New Digital User

03 Health Services

How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation